Format

Send to

Choose Destination
Int J Biochem Cell Biol. 2011 May;43(5):701-4. doi: 10.1016/j.biocel.2011.01.020. Epub 2011 Feb 2.

Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.

Author information

1
School of Life Sciences & State Key Laboratory of Oral Diseases, Sichuan University, Chengdu 610064, China.

Abstract

It is well-known that cell cycle arrest and/or death play a pivotal role in tumor progression, which has drawn a rising attention for cancer biologists due to their complex and intricate relationships. In this review, we demonstrate the recent research on oridonin, an active diterpenoid with remarkable anti-proliferative activities, and then further explore its molecular mechanisms of cell cycle arrest, apoptosis, autophagy and their cross-talks in various cancer cells, which may provide a new perspective of oridonin as a candidate anti-neoplastic drug for future cancer therapeutics.

PMID:
21295154
DOI:
10.1016/j.biocel.2011.01.020
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center